# Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain

> **NCT00788801** · PHASE1 · COMPLETED · sponsor: **Abbott** · enrollment: 11 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** ABT-614

## Key facts

- **NCT ID:** NCT00788801
- **Lead sponsor:** Abbott
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2009-03
- **Final completion:** —
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2010-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00788801

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00788801, "Exploratory Positron Emission Tomography (PET) Study to Evaluate the Effects of ABT-614 on [11C]-(+)-PHNO Binding Potential to D3 Receptors in the Brain". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00788801. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*